Global Digital Genome Market to amass $50.4 Bn by 2025

December 26, 2019


As per the latest research report with title ‘Digital Genome Market Size By Product (Sequencing & Analyzer Instruments, DNA/RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Preparation Instruments), By Application (Microbiology {Biological, Clinical, Industrial}, Reproductive & Genetic, Transplantation, Livestock and Agriculture, Forensics, Research and Development), By End-Use (Diagnostics & Forensic Labs, Academic Research Institutes, Hospitals, Bio-Pharmaceutical Companies) Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’ available with Market Study Report LLC, the global digital genome market is expected to accumulate US $50.4 billion by the year 2025.
 

Growing prevalence of chronic diseases due to sedentary lifestyle and consumption of unhealthy substances among the global population is the main driver for digital genome market growth. Developments in biotechnology, along with shifting preference across animal & plant sciences for molecular systematics to study evolution in organisms will further augment the market outlook. Genomic technology, when coupled with next generation techniques result in faster DNA sequencing at low cost. This, in tandem with shifting trend of developing personalized drugs for clinical diagnosis are presumed to impel the growth of digital genome market in the upcoming years.
 

Though, governments of several nations are promoting genomic technology to improvise medical practices, but lack of expertise in the field, high cost of personalized medicines, low awareness regarding the applications of technology, imprecise findings, and safety issues are impeding the growth of digital genome market to some extent.
 

Based on product, sequencing chips segment of digital genome market is witnessing high demand owing to evolution of epigenetic studies. These chips are used to analyze the effect of transcription factors and chromatin proteins on phenotypic mechanisms. The ability of next gen sequencing chips to offer understanding about relation between gene regulation and genetic disorders will fuel the segmental growth.
 

Speaking of application spectrum, digital genome market from agriculture & livestock is anticipated to register accelerated growth over the forecast period. Genetic tests are performed on livestock to reckon various traits like tenderness of meat, high milk yield, efficient nutrient utilization, faster weight gain, and disease resistance.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/467589/
 

Considering end-use industry, hospitals segment will contribute heavily towards the growth of digital genome market over the forthcoming period. Numerous physicians are adopting advanced gene editing techniques like bio-python, next gen sequencing, and computer aided drug delivery to understand genetic variability and to process personalized drugs for patients. Widespread use of genomics for drug discovery, diagnosis, drug reaction prevention, and transplanting will bolster the overall market share.
 

The prominent contenders functioning in digital genome market include NanoString Technologies, Inc., Inscripta, Inc., Illumina, GenMark Diagnostics, Inc., Genomic Health, Inc., GE Healthcare, F. Hoffmann-La Roche Ltd., Becton Dickinson & Company, bioMerieux, and Agilent Technologies, Inc. among others.


Frequently Asked Questions (FAQ) :

Growing prevalence of chronic diseases due to sedentary lifestyle and consumption of unhealthy substances among the global population is the main driver for digital genome market growth. Developments in biotechnology, along with shifting preference across animal & plant sciences for molecular systematics to study evolution in organisms will further augment the market outlook. Genomic technology, when coupled with next generation techniques result in faster DNA sequencing at low cost. This, in tandem with shifting trend of developing personalized drugs for clinical diagnosis are presumed to impel the growth of digital genome market in the upcoming years.
Based on product, sequencing chips segment of digital genome market is witnessing high demand owing to evolution of epigenetic studies. These chips are used to analyze the effect of transcription factors and chromatin proteins on phenotypic mechanisms. The ability of next gen sequencing chips to offer understanding about relation between gene regulation and genetic disorders will fuel the segmental growth.
Speaking of application spectrum, digital genome market from agriculture & livestock is anticipated to register accelerated growth over the forecast period. Genetic tests are performed on livestock to reckon various traits like tenderness of meat, high milk yield, efficient nutrient utilization, faster weight gain, and disease resistance.
The prominent contenders functioning in digital genome market include NanoString Technologies, Inc., Inscripta, Inc., Illumina, GenMark Diagnostics, Inc., Genomic Health, Inc., GE Healthcare, F. Hoffmann-La Roche Ltd., Becton Dickinson & Company, bioMerieux, and Agilent Technologies, Inc. among others.